SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to the accelerated path of its oral obesity drug, VK2735, directly into Phase 3 following positive FDA feedback, fueling community discussions about a significant short squeeze and potential lucrative partnership or acquisition in the booming GLP-1 market.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly Inc is trending after reporting a significant earnings beat and robust guidance, marking its first profitable fiscal year with record revenue and gross margins. The community is actively discussing this as a potential turnaround story, driven by new leadership and increasing AI tailwinds in the edge computing sector, though some remain cautious given its past.

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

NovoCure is trending following U.S. FDA approval of Optune Pax for locally advanced pancreatic cancer, hailed by the community as the first significant new treatment for this aggressive disease in decades. This breakthrough, supported by positive Phase 3 trial data, is fueling intense speculation of a massive short squeeze and substantial future growth, despite some cautionary perspectives on past stock volatility.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape's recent earnings call disappointed some investors with a lack of specific commercialization timelines and production yields, triggering an after-hours stock drop. However, the company's newly operational Eagle Line pilot facility is now shipping B-samples to multiple OEMs, with apparent involvement from Nissan and Hitachi, sparking bullish hopes for scalable solid-state battery production and future licensing deals.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Energy and Transportation, Financial Products, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Energy and Transportation segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The Financial Products segment provides financing alternatives to customers and dealers for Caterpillar products and services, as well as financing for power generation facilities. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925 and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillar is trending after reporting strong earnings, with its power generation segment surging due to robust demand for turbines and gensets from AI data centers, leading to record highs and analyst upgrades. The community is actively discussing whether its current valuation is justified, as the industrial giant is now viewed by many as a key beneficiary of the ongoing AI infrastructure buildout.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco Systems is trending after reporting a Q1 earnings beat and raising its full-year guidance, largely driven by strong AI infrastructure orders. The community is actively discussing its pivotal role in the AI buildout and the notable historical context of its stock price approaching dot-com era highs.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings is surging following robust earnings and an upbeat outlook, driven by record organic orders and a massive backlog for its critical power and thermal management solutions, essential for the accelerating buildout of AI data center infrastructure. The community is actively discussing its valuation while affirming its key "picks and shovels" role in the AI supercycle, differentiating its offerings from server providers.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

UniSwap (UNI) is trending amidst significant community discussion following a BlackRock investment and an impending governance vote on the "UNIfication" proposal, which includes activating a protocol fee switch and burning a substantial amount of UNI tokens. While some note muted price action in current market conditions, many in the community view these developments as strongly bullish for UNI's long-term value and sustainability.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software Inc. is trending as its shares plunged following Q4 earnings that beat estimates but were overshadowed by soft Q1 guidance. The community is divided, with bulls seeing the deep discount as an overreaction fueled by strong Vector Ads growth and upcoming AI integrations, while bears remain cautious about persistent losses and increasing AI competition from rivals.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

The FDA's refusal to review Moderna's mRNA flu vaccine application is driving significant discussion, with many in the community believing this creates a major advantage for Novavax's correctly designed protein-based flu and COVID-flu combination trials. This development, coupled with notable institutional buying, intensifies calls for strategic partnerships or a company buyout to realize the stock's potential value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vanda Pharmaceuticals Q4 Earnings Call Highlights

Vanda Pharmaceuticals (NASDAQ:VNDA) highlighted strong growth for its lead product Fanapt and detailed several late-stage regulatory and clinical milestones during its fourth-quarter and full-year...

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates

Vanda (VNDA) delivered earnings and revenue surprises of +78.85% and -2.78%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Vanda Pharmaceuticals (NASDAQ:VNDA) Issues Quarterly Earnings Results, Beats Expectations By $0.99 EPS

Vanda Pharmaceuticals (NASDAQ:VNDA - Get Free Report) released its earnings results on Wednesday. The biopharmaceutical company reported ($0.46) earnings per share for the quarter, beating analysts...

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire WASHINGTON, Feb. 11...

Gilead Sciences (GILD) Surpasses Q4 Earnings and Revenue Estimates

Gilead (GILD) delivered earnings and revenue surprises of +1.91% and +4.63%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Up 23.3% in January

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 15th, there was short interest...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Intellia Therapeutics (NTLA) Surges 6.3%: Is This an Indication of Further Gains?

Intellia Therapeutics (NTLA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Receives Average Rating of "Moderate Buy" from Analysts

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six ratings firms that are currently covering the firm, MarketBeat.com reports...

$VNDA Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of -$2.39 down -2887.50% YoY
• Vanda Pharmaceuticals Inc. expects 2026 total revenues to be between $230M and $260M, with Fanapt net product sales projected at $150M to $170M, and other net product sales at $80M to $90M.

Stocktwits

Vanda Pharmaceuticals Inc

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of -$2.39 down -2887.50% YoY
• Vanda Pharmaceuticals Inc. expects 2026 total revenues to be between $230M and $260M, with Fanapt net product sales projected at $150M to $170M, and other net product sales at $80M to $90M.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COIN earnings on Thursday?

Coinbase Global Inc

Stocktwits Polls

Many traders are eyeing a potential short squeeze, citing over 50% short interest on a tight public float of 2.9 million shares, hinting at algorithmic manipulation.

Significant excitement surrounds the upcoming Phase 3 trial for Tradipitant, which aims to prevent GLP-1 analogue induced vomiting, with many seeing it as a 'mega blockbuster potential market'.

Anticipation is building for the FDA's February 21st PDUFA decision regarding Bysanti, with many investors front-running the potential approval catalyst.

Traders are actively speculating on significant upward price movements, with various targets ranging from $8.50 to $15 per share after expected catalysts and new product approvals.

Discussions focus on the recently reported Q4 GAAP EPS of -$2.39 and the 2026 revenue guidance between $230M and $260M, as investors evaluate current financials and future outlook.

VNDA
Vanda Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VNDA News

VNDAVanda Pharmaceuticals Inc